These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

350 related items for PubMed ID: 8524391

  • 1. Structure and ligand recognition of the phosphotyrosine binding domain of Shc.
    Zhou MM, Ravichandran KS, Olejniczak EF, Petros AM, Meadows RP, Sattler M, Harlan JE, Wade WS, Burakoff SJ, Fesik SW.
    Nature; 1995 Dec 07; 378(6557):584-92. PubMed ID: 8524391
    [Abstract] [Full Text] [Related]

  • 2. Crystal structures of the SH2 domain of Grb2: highlight on the binding of a new high-affinity inhibitor.
    Nioche P, Liu WQ, Broutin I, Charbonnier F, Latreille MT, Vidal M, Roques B, Garbay C, Ducruix A.
    J Mol Biol; 2002 Feb 01; 315(5):1167-77. PubMed ID: 11827484
    [Abstract] [Full Text] [Related]

  • 3. Recognition of a high-affinity phosphotyrosyl peptide by the Src homology-2 domain of p56lck.
    Eck MJ, Shoelson SE, Harrison SC.
    Nature; 1993 Mar 04; 362(6415):87-91. PubMed ID: 7680435
    [Abstract] [Full Text] [Related]

  • 4. Shc binding to nerve growth factor receptor is mediated by the phosphotyrosine interaction domain.
    Dikic I, Batzer AG, Blaikie P, Obermeier A, Ullrich A, Schlessinger J, Margolis B.
    J Biol Chem; 1995 Jun 23; 270(25):15125-9. PubMed ID: 7541035
    [Abstract] [Full Text] [Related]

  • 5. Solution structure of the SH2 domain of Grb2 complexed with the Shc-derived phosphotyrosine-containing peptide.
    Ogura K, Tsuchiya S, Terasawa H, Yuzawa S, Hatanaka H, Mandiyan V, Schlessinger J, Inagaki F.
    J Mol Biol; 1999 Jun 11; 289(3):439-45. PubMed ID: 10356320
    [Abstract] [Full Text] [Related]

  • 6. Solution structure of the C-terminal SH2 domain of the p85 alpha regulatory subunit of phosphoinositide 3-kinase.
    Siegal G, Davis B, Kristensen SM, Sankar A, Linacre J, Stein RC, Panayotou G, Waterfield MD, Driscoll PC.
    J Mol Biol; 1998 Feb 20; 276(2):461-78. PubMed ID: 9512716
    [Abstract] [Full Text] [Related]

  • 7. Crystal structure of the SH2 domain from the adaptor protein SHC: a model for peptide binding based on X-ray and NMR data.
    Mikol V, Baumann G, Zurini MG, Hommel U.
    J Mol Biol; 1995 Nov 17; 254(1):86-95. PubMed ID: 7473762
    [Abstract] [Full Text] [Related]

  • 8. Dissection of the energetic coupling across the Src SH2 domain-tyrosyl phosphopeptide interface.
    Lubman OY, Waksman G.
    J Mol Biol; 2002 Feb 15; 316(2):291-304. PubMed ID: 11851339
    [Abstract] [Full Text] [Related]

  • 9. Re-engineering the target specificity of the insulin receptor by modification of a PTB domain binding site.
    van der Geer P, Wiley S, Pawson T.
    Oncogene; 1999 May 20; 18(20):3071-5. PubMed ID: 10340378
    [Abstract] [Full Text] [Related]

  • 10. A conserved amino-terminal Shc domain binds to phosphotyrosine motifs in activated receptors and phosphopeptides.
    van der Geer P, Wiley S, Lai VK, Olivier JP, Gish GD, Stephens R, Kaplan D, Shoelson S, Pawson T.
    Curr Biol; 1995 Apr 01; 5(4):404-12. PubMed ID: 7542991
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Backbone dynamics of the C-terminal SH2 domain of the p85alpha subunit of phosphoinositide 3-kinase: effect of phosphotyrosine-peptide binding and characterization of slow conformational exchange processes.
    Kristensen SM, Siegal G, Sankar A, Driscoll PC.
    J Mol Biol; 2000 Jun 09; 299(3):771-88. PubMed ID: 10835283
    [Abstract] [Full Text] [Related]

  • 19. The three-dimensional solution structure of the SH2 domain from p55blk kinase.
    Metzler WJ, Leiting B, Pryor K, Mueller L, Farmer BT.
    Biochemistry; 1996 May 21; 35(20):6201-11. PubMed ID: 8639560
    [Abstract] [Full Text] [Related]

  • 20. Structural basis for the high affinity of amino-aromatic SH2 phosphopeptide ligands.
    Rahuel J, García-Echeverría C, Furet P, Strauss A, Caravatti G, Fretz H, Schoepfer J, Gay B.
    J Mol Biol; 1998 Jun 19; 279(4):1013-22. PubMed ID: 9642078
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.